I agree that this site is using cookies. You can find further informations here.
X
Lucas, Andrew T.
7359  results:
Search for persons X
?
1

Absence of hyperfibrinolysis may explain lack of efficacy o..:

Ilich, Anton ; Gernsheimer, Terry B. ; Triulzi, Darrell J....
Blood Advances.  7 (2023)  6 - p. 900-908 , 2023
Link: https://doi.org/10.1182/..
 
?
2

Complex Factors and Challenges that Affect the Pharmacology..:

Piscatelli, Joseph A. ; Ban, Jisun ; Lucas, Andrew T..
Pharmaceutics.  13 (2021)  1 - p. 114 , 2021
Link: https://doi.org/10.3390/..
 
?
3

Importance and Considerations of Antibody Engineering in An..:

Lucas, Andrew T. ; Moody, Amber ; Schorzman, Allison N..
Antibodies.  10 (2021)  3 - p. 30 , 2021
Link: https://doi.org/10.3390/..
 
?
4

Pharmacologic Considerations in the Disposition of Antibodi..:

Lucas, Andrew T. ; Robinson, Ryan ; Schorzman, Allison N....
Antibodies.  8 (2019)  1 - p. 3 , 2019
Link: https://doi.org/10.3390/..
 
?
5

Pretargeted delivery of PEG-coated drug carriers to breast ..:

Parker, Christina L. ; McSweeney, Morgan D. ; Lucas, Andrew T....
Nanomedicine: Nanotechnology, Biology and Medicine.  21 (2019)  - p. 102076 , 2019
Link: https://doi.org/10.1016/..
 
?
6

Mononuclear phagocyte system function and nanoparticle phar..:

Starling, Brittney R. ; Kumar, Parag ; Lucas, Andrew T....
Cancer Chemotherapy and Pharmacology.  83 (2018)  1 - p. 61-70 , 2018
Link: https://doi.org/10.1007/..
 
?
7

Animal models for analysis of immunological responses to na..:

Zamboni, William C. ; Szebeni, Janos ; Kozlov, Serguei V....
Advanced Drug Delivery Reviews.  136-137 (2018)  - p. 82-96 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Profiling the relationship between tumor-associated macroph..:

Lucas, Andrew T. ; White, Taylor F. ; Deal, Allison M....
Nanomedicine: Nanotechnology, Biology and Medicine.  13 (2017)  2 - p. 471-482 , 2017
Link: https://doi.org/10.1016/..
 
?
9

Pharmacokinetic and screening studies of the interaction be..:

Lucas, Andrew T. ; Herity, Leah B. ; Kornblum, Zack A....
International Journal of Pharmaceutics.  526 (2017)  1-2 - p. 443-454 , 2017
Link: https://doi.org/10.1016/..
 
?
10

Translation to the Clinic: Preclinical and Clinical Pharmac..:

, In: Pharmaceutical Nanotechnology: Innovation and Production,
Tyson, Rachel ; Osae, Leah ; Madden, Andrew J... - p. 469-496 , 2016
Link: https://doi.org/10.1002/..
 
?
11

Challenges in preclinical to clinical translation for antic..:

Lucas, Andrew T. ; Madden, Andrew J. ; Zamboni, William C.
WIREs Nanomedicine and Nanobiotechnology.  8 (2016)  5 - p. 642-653 , 2016
Link: https://doi.org/10.1002/..
 
?
12

Determining the Need for Standardized Infusions and Concent..:

Lucas, Andrew T. ; Rowe, Erinn ; Eckel, Stephen F.
Hospital Pharmacy.  51 (2016)  3 - p. 237-245 , 2016
Link: https://doi.org/10.1310/..
 
?
13

Gulp1 is associated with the pharmacokinetics of PEGylated ..:

Song, Gina ; Suzuki, Oscar T. ; Santos, Charlene M....
Nanomedicine: Nanotechnology, Biology and Medicine.  12 (2016)  7 - p. 2007-2017 , 2016
Link: https://doi.org/10.1016/..
 
?
14

A sensitive high performance liquid chromatography assay fo..:

Lucas, Andrew T. ; O'Neal, Sara K. ; Santos, Charlene M...
Journal of Pharmaceutical and Biomedical Analysis.  119 (2016)  - p. 122-129 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Ligand Binding Reveals a Role for Heme in Translationally-C..:

Lucas, Andrew T. ; Fu, Xiangping ; Liu, JingJing...
PLoS ONE.  9 (2014)  11 - p. e112823 , 2014
Link: https://doi.org/10.1371/..
 
1-15